Crescent BDC (CCAP) Q2 2026 earnings review
NAV Bleed Continues as Leverage Breaches Limits
Crescent BDC posted another challenging quarter marked by a decelerating top line, mounting credit losses, and ballooning leverage. Net Investment Income (NII) fell to $0.36 per share, down from $0.42 sequentially and $0.46 a year ago. While NII barely covers the newly 'reset' base dividend of $0.34, the broader balance sheet is under severe stress. Net Asset Value (NAV) per share dropped to $17.82, driven by a massive $17.7M in realized losses. Crucially, the company's net debt-to-equity ratio accelerated to 1.37x, well outside management's 1.1x-1.3x target range, severely limiting its ability to grow the portfolio.
🐂 Bull Case
Despite the sharp NII decline to $0.36 per share, it still adequately covers the lowered Q3 base dividend of $0.34, validating management's decision to reset the payout level in Q1.
The portfolio remains heavily concentrated at the top of the capital structure, with Unitranche and Senior Secured First Lien debt comprising 90% of total investments, mitigating ultimate loss severity.
🐻 Bear Case
Net debt-to-equity hit 1.37x, blowing past the 1.30x upper limit. This forces the company into defensive mode, prioritizing debt paydown over lucrative new originations.
Realized losses spiked to $17.7M. NAV has now fallen for five consecutive quarters, suggesting fundamental flaws in recent underwriting vintages.
⚖️ Verdict: 🔴
Bearish. The combination of falling portfolio yields, a maxed-out balance sheet, and accelerating realized credit losses paints a bleak picture. Without room to expand the portfolio, Crescent BDC must shrink to survive.
Key Themes
Leverage Ceiling Breached
An accelerating concern: net debt-to-equity jumped from 1.32x in Q1 to 1.37x in Q2, completely breaking management's stated target range of 1.1x to 1.3x. This limits the company's flexibility. With limited room to borrow, gross deployment was highly muted at just $57.0M.
Realized Losses Spike
The credit distress flagged in Q1 (which brought 5 new non-accruals) has translated into permanent capital destruction. Net realized losses on investments hit $17.7 million, accelerating severely from $11.6 million in Q1 and just $2.9 million in the prior-year quarter. The portfolio is taking actual hits, not just paper markdowns.
Macro Rate Pressures Crushing Yields
The company's heavy exposure to floating-rate debt (98.4% of the portfolio) is acting as a massive macro headwind. The weighted average yield on income-producing securities has been decelerating sharply, falling from 10.4% in 25Q2 to 9.8% in 26Q1, and now 9.6% in 26Q2. Lower base rates are directly eroding the top line.
Logan JV Dividend Income Collapse
A specific structural drag on Q2 revenue was a massive drop in dividend income, which fell to $1.2M from $3.0M sequentially. Management explicitly blamed lower distributions from the company's First Eagle Logan JV investment. If this joint venture vehicle continues to underperform, NII will face sustained pressure.
Structural Fee Cuts Cushion the Blow
The permanent fee reductions enacted in April 2026—cutting the base management fee to 1.00% (from 1.25%) and the incentive fee to 15.0% (from 17.5%)—were crucial this quarter. Without this structural change, the NII drop to $0.36 would have been far worse. Total net expenses stabilized at $23.2 million.
Cash-Flow Based Software Lending & Unitranche Structure
Despite broader distress, management's product structure strategy focuses heavily on cash-flow-based Unitranche loans (66.2% of the portfolio), intentionally avoiding Annual Recurring Revenue (ARR) based software loans. This disciplined approach to structuring high-LTV tech deals provides some downside protection amid tech-sector valuation pressure.
Other KPIs
Decelerating. Down from $37.9M sequentially and $43.0M a year ago. Driven by lower Logan JV dividends and reduced accelerated amortization/prepayment fees, offsetting modestly higher recurring interest income ($34.7M).
Declining steadily. Down from $674.0M in 26Q1 and $724.7M in 25Q2. The combined impact of dividend payouts exceeding NII in previous quarters, plus massive realized and unrealized losses, is shrinking the equity base.
Guidance
Stable sequentially, but represents a 19% deceleration/decline YoY compared to the $0.42 base dividend paid in 25Q3. The company also declared a $0.03 special dividend (the second of three previously announced installments).
Key Questions
Path to Leverage Normalization
With net debt-to-equity at 1.37x, far above the 1.3x ceiling, what is the specific timeline and mechanism for deleveraging? Will this require forced asset sales at unfavorable marks?
Anatomy of Realized Losses
Net realized losses spiked to $17.7 million this quarter. Did these stem from the specific healthcare non-accruals flagged in Q1, or are new sectors showing distress?
Logan JV Outlook
Dividend income from the Logan JV dropped severely from $3.0M to $1.2M. Is this a permanent step-down reflecting underlying credit issues in the JV, or merely timing of cash flows?